Colitis ulcerosa: vizsgálatok itt: Grúzia
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleExtension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Where
- Tbilisi
- Életkor
- 18 év and over
- People
- 1380 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00 - 2. fázisCsak meghívásosLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Kutaisi, Marneuli, Tbilisi
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 1/2. fázisTaking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Tbilisi
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Kutaisi, Marneuli, Tbilisi
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Kutaisi, Tbilisi
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 2. fázisTaking peopleConfirmatory Clinical Study in Active Ulcerative Colitis
- Where
- Kutaisi, Tbilisi
- Életkor
- 16 év and over
- People
- 204 worldwide
- Run by
- MRM Health NV
See details and how to joinNCT07296315 · EU 2025-524682-24-00 - 2. fázisTaking peopleA Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Batumi, Tbilisi
- Életkor
- 18 év to 75 év
- People
- 204 worldwide
- Run by
- Palisade Bio
See details and how to joinNCT07845487 - 1/2. fázisTaking peopleA Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
- Where
- Tbilisi
- Életkor
- 18 év to 75 év
- People
- 100 worldwide
- Run by
- Mage Biologics
See details and how to joinNCT07374471 · EU 2025-524719-35-00 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Kutaisi, Tbilisi
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 2. fázisTaking peopleA Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Where
- Kutaisi, Marneuli, Tbilisi
- Életkor
- 18 év to 80 év
- People
- 140 worldwide
- Run by
- Mirador Therapeutics, Inc.
See details and how to joinNCT07113522